Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • imsharmanitin
    Postdoc Cancer Bioinformatics
    • Dec 2014
    • 17

    #1

    is this a technical replicate or biological replicate

    i know that biological replicate is one taken from different organism/sample while technical replicate is one from same organism/sample.

    However, I am not able to understand that a cell line treated with a drug three times separately to generate RNA-Seq data will be considered as biological replicate or technical replicate or a biological replicate but not in a strict sense. Also, will this be applicable for control sample?

    Thanks in advance
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    I think it would be biological replicates and the same goes for control which should be treated with solvent without the drug. I imagine that there will be other treatments such as exposure time and dose as well in such experiments.

    Comment

    • jaspersaris
      Member
      • Nov 2008
      • 6

      #3
      As the variation during cultering is expected (and often is) far more variable then the technical reproducibility the biological replicate would be to repeat the actual incubations i.e. three times (for a triplicate).
      A technical replicate would be having the same RNA sample sequenced two times (i.e. a duplo).
      Often an experiment is repeated three times, getting n=3 for the experiment and statistics. In the experiment an incubation can be in duplo (i.e. two flasks stimulated with the same compound). Each incubation is then sequenced once.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...